Cargando…

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC

OBJECTIVES: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) has significant therapeutic efficacy in non‐small‐cell lung cancer (NSCLC) patients. However, acquired resistance is inevitable and limits the long‐term efficacy of EGFR‐TKI. Our study aimed to investigate the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jianmin, Zhou, Pu, Wang, Xudong, Yu, Yongxin, Zhu, Guangkuo, Zheng, Linpeng, Xu, Zihan, Li, Feng, You, Qiai, Yang, Qiao, Zhuo, Wenlei, Sun, Jianguo, Chen, Zhengtang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536583/ https://www.ncbi.nlm.nih.gov/pubmed/30848009 http://dx.doi.org/10.1111/cpr.12592

Ejemplares similares

The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer
por: You, Qiai, et al.
Publicado: (2022)

Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor
por: Xu, Zihan, et al.
Publicado: (2019)

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
por: Xu, Zihan, et al.
Publicado: (2019)

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients
por: Yang, Qiao, et al.
Publicado: (2021)

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC
por: Krentz Gober, Madeline, et al.
Publicado: (2017)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
por: Feng, Yongdong, et al.
Publicado: (2021)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Vector-Mediated Selective Expression of Lethal Factor, a Toxic Element of Bacillus Anthracis, Damages A549 Cells via Inhibition of MAPK and AKT Pathways
por: Zhuo, Wenlei, et al.
Publicado: (2013)

Rab proteins move integrins
por: Tuma, Rabiya S.
Publicado: (2006)

Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer
por: Condello, Salvatore, et al.
Publicado: (2022)

Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins
por: Pellinen, Teijo, et al.
Publicado: (2006)

The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/Stat 5/β-Catenin Signaling Pathway
por: Liao, Jinrong, et al.
Publicado: (2020)

HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC
por: Tseng, Ruo-Chia, et al.
Publicado: (2014)

ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway
por: Zhan, Wei, et al.
Publicado: (2020)

An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development
por: Wang, Rui, et al.
Publicado: (2021)

NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling
por: Qu, Lianyue, et al.
Publicado: (2022)

In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
por: Fan, Di, et al.
Publicado: (2023)

Rab11 is Required for Maintenance of Cell Shape Via βPS Integrin Mediated Cell Adhesion in Drosophila
por: Bhuin, Tanmay, et al.
Publicado: (2012)

Epidermal growth factor-mediated Rab25 pathway regulates integrin β1 trafficking in colon cancer
por: Hong, Kyung Sook, et al.
Publicado: (2018)

Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
por: Kim, Young, et al.
Publicado: (2009)

Klf5 controls bone marrow homing of stem cells and progenitors through Rab5-mediated β1/β2-integrin trafficking
por: Taniguchi Ishikawa, E., et al.
Publicado: (2013)

Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma
por: Yang, Xian-Zi, et al.
Publicado: (2020)

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis
por: Di Modugno, Francesca, et al.
Publicado: (2018)

Roles of Integrin α6β4 Glycosylation in Cancer
por: Kariya, Yoshinobu, et al.
Publicado: (2017)

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells
por: Renner, Guillaume, et al.
Publicado: (2016)

MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
por: SU, JUAN, et al.
Publicado: (2011)

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis
por: Yang, Qiao, et al.
Publicado: (2019)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
por: Nishio, Kazuto, et al.
Publicado: (2021)

H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC
por: Carotenuto, Marianeve, et al.
Publicado: (2014)

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway
por: Tang, Ze, et al.
Publicado: (2018)

Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway
por: You, Yang, et al.
Publicado: (2015)

Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability
por: Lin, Zhikun, et al.
Publicado: (2018)

Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
por: Zheng, LinPeng, et al.
Publicado: (2019)

Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway
por: Jian, Qiang, et al.
Publicado: (2015)

Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis
por: Do, M T, et al.
Publicado: (2017)

Jaceosidin inhibits the progression and metastasis of NSCLC by regulating miR-34c-3p/Integrin α2β1 axis
por: Guo, Qiao-ru, et al.
Publicado: (2023)

Ursolic Acid Attenuates TGF-β1-Induced Epithelial–Mesenchymal Transition in NSCLC by Targeting Integrin αVβ5/MMPs Signaling
por: Ruan, Jun Shan, et al.
Publicado: (2019)

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
por: Ramella, Sara, et al.
Publicado: (2013)

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
por: Li, Yang-Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0noorjeons1b913hn2lideh0ap